MKI67 and ductal breast carcinoma in situ: - Non-significant difference in decrease of ln (Ki67) for both invasive and DCIS breast cancers (p= 0.98) or invasive breast cancer alone (p = 0.43).- No significant variation noted in changes of ln (Ki67) when metformin arm compared to control arm (p = .47).